Edition:
United States

CytomX Therapeutics Inc (CTMX.OQ)

CTMX.OQ on NASDAQ Stock Exchange Global Select Market

22.75USD
1:00pm EDT
Change (% chg)

$0.26 (+1.16%)
Prev Close
$22.49
Open
$22.44
Day's High
$22.75
Day's Low
$22.03
Volume
20,562
Avg. Vol
175,305
52-wk High
$34.98
52-wk Low
$13.57

Chart for

About

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company. The Company uses its Probody technology platform to create cancer immunotherapies against clinically validated targets, as well as to develop cancer therapeutics against difficult-to-drug targets. Its pipeline is focused on the development... (more)

Overall

Beta: --
Market Cap(Mil.): $1,006.90
Shares Outstanding(Mil.): 44.77
Dividend: --
Yield (%): --

Financials

  CTMX.OQ Industry Sector
P/E (TTM): -- 99.36 30.45
EPS (TTM): -1.68 -- --
ROI: -21.97 2.89 12.63
ROE: -137.66 1.65 14.82

BRIEF-CytomX Therapeutics Q1 Revenue $14.2 Mln Vs I/B/E/S View $16.4 Mln

* CYTOMX THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

May 09 2018

BRIEF-Cytomx Therapeutics Provides Operational Update

* CYTOMX THERAPEUTICS ANNOUNCES FULL-YEAR 2017 FINANCIAL RESULTS AND PROVIDES OPERATIONAL UPDATE

Mar 07 2018

Competitors

  Price Chg
AstraZeneca plc (AZN.L) 5,979.00 +49.00
GlaxoSmithKline plc (GSK.L) 1,619.40 +2.40
Merck & Co., Inc. (MRK.N) $70.07 +1.01
Novartis AG (NOVN.S) CHF82.88 +0.40
Pfizer Inc. (PFE.N) $42.47 +0.38
Roche Holding Ltd. (ROG.S) CHF242.00 +2.05
Roche Holding Ltd. (RO.S) CHF245.80 +2.60
Sanofi SA (SASY.PA) €73.43 +0.13
ImmunoGen, Inc. (IMGN.OQ) $9.16 +0.22
Seattle Genetics, Inc. (SGEN.OQ) $74.46 -0.18

Earnings vs. Estimates